Gingivitis Clinical Trial
Official title:
Clinical Preliminary Evidence of the Efficacy of a Mouthwash Containing 5% Propolis for the Control of Plaque and Gingivitis: Phase II Study
Mouthwash based on medicinal plants and propolis can be easily found in the Brazilian market even if it has not been tested in reliable clinical trials on its efficacy or possible unpleasant side effects like the ones which alter the hard and soft oral tissues. The aim of this study was to obtain preliminary evidence of efficacy of an alcohol-free mouthwash containing 5% green propolis (MGP 5%) on the control of plaque and gingivitis. Were chosen twenty-five subjects that are UFMG employees and individuals who would begin treatment on an extension project called Supportive Periodontal Therapy at the Faculty of Dentistry of Federal University of Minas Gerais, Belo Horizonte, from August to December 2009. The subjects went through a dental prophylaxis before starting rinse. They were then instructed to rinse twice a day for a minute, immediately after brushing (morning and night), using the 10 ml of the MGP 5%. After 45 and 90 days using the product the individuals returned for a clinical evaluation which considered changes in the soft and hard oral tissues and involved collecting plaque and gingivitis indexes. On their last appointment the subjects answered a questionnaire about their level of appreciation and acceptability of the mouthwash. Compliance with the treatment was also evaluated through an attendance form. For the statistic analysis we used BioEstat 4.0 and Excel 2007.
The first reference to mouthrinse as a formal practice is credited to Chinese medicine,
about 2700 B.C.E., to treatment the diseases of the gums (Fischman, 1997).
The gram-positive and gram-negative bacteria that compose oral biofilms produces many
metabolites that induce gingival inflammation (that is, gingivitis). Gingivitis can lead to
periodontitis, a condition in which gingival and bone tissues are destroyed. The majority of
the population may not perform mechanical plaque removal sufficiently. Thus, antimicrobial
mouthrinses that improve daily home care may provide an effective way of removing or
controlling bacterial plaque to limit gingivitis and periodontitis (Haffajee et al., 2008).
The main indications are either the improvement of dental health (plaque and gingivitis
elimination in particular) or the prevention of infections caused by bacteria of the oral
cavity in specific situations, such as tooth extraction, intraoral surgical procedures or
immune suppression due to cancer therapy or transplantation. The use of antimicrobial
mouthrinses has been proposed to reduce the levels of oral bacteria, specially Streptococcus
mutans (Kocak et al., 2009).
In fact, it has been shown that chemotherapeutic mouthrinses are an effective adjunct to
regular brushing and flossing for patients with gingivitis, providing a clinically
significant benefit in the reduction of plaque and gingivitis (Haffajee et al., 2008).
Propolis is a resinous substance collected by honeybees from buds and exudates of certain
trees and plants, and stored inside their hives. It has been used in folk medicine from
ancient times to treat various ailments (Kunimasa et al., 2009).
The action against microorganisms is an essential characteristic of propolis, and humans
have used it for centuries for its pharmaceutical properties (Kalogeropoulos et al., 2009).
The antibacterial activity of propolis is reported due to flavonoids, aromatic acids and
esters present in resins. Galangin, pinocebrin and pinostrobin are known as the flavonoids
agents more effective against bacteria. Ferulic acid and caffeic acid also contribute to the
bactericidal action of propolis (Marcucci, 1995). Thus, the purpose of this study was to
show a preliminary evidence about the effect of an alcohol-free mouthwash containing 5% of
green propolis for the control of plaque and gingivitis in subjects for three months.
Materials and Methods
Design study and Product tested
This was an interventional study of phase II for three months, follow up type, and was
conducted at the Faculty of Dentistry of Federal University of Minas Gerais, Brazil, from
August 2009 to April 2010.
The alcohol-free mouthwash containing 5% green propolis (MGP 5%) used in that study was
handled according to our request by PharmaNéctar ® (Belo Horizonte), within the standards
required by ANVISA (Brazil, 2000) and within the requirements of ISO 9001 and GMP
International (Table 1).
Participants
Twenty five subjects, age varying from 18 to 60 years (median age 35,92 ±9,7), with
generally good health, not pregnant nor breastfeeding, who met the following inclusion
criteria, were included into the study: a minimum of 20 sound, natural teeth; a mean plaque
index (PI) (Turesky modification of the Quigley-Hein Plaque Index, 1970) of at least 1.5; a
mean gingival index (GI) (Talbott modification Gingival Index of the Löe-Silness, 1977) of
at least 1.0. Subjects with orthodontic appliances or removable prosthetics, tumors of the
soft or hard oral tissues, advanced periodontal disease, or that received antibiotic therapy
2 weeks before the start of the study or that presented hipersensibility to propolis were
excluded. Third molars and those teeth with cervical restorations or prosthetic crowns were
not included in the tooth count. The selection of participants was made by convenience,
based especially on the availability for the study, along the study was conducted. All
subjects read and signed informed consent forms before the start of the study. The protocol
for the study was approved by the local ethical review committee (Committee of Bioethics in
Research at the Federal University of Minas Gerais (COEP/UFMG - 0600/09).
Assessing mouthwash
The examination baseline consisted of a complete soft and hard tissues examination that was
performed to register the condition of oral mucosa, so that any changes in the course of the
study could be identified , making assessment to whether these changes could be related to
the mouthrinse. The gingivitis of the mesiobuccal, midbuccal, distobuccal, mesiolingual,
midlingual, and distolingual, of all elegible teeth was scored using the Talbott
modification Gingival Index of the Löe-Silness - GI, 1977, in which the gum was scored on a
four-point scale from 0 (absence of inflammation) to 3 ( severe inflammation). The
supragingival plaque of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual,
and distolingual, of all elegible teeth was scored using the Turesky modification of the
Quigley-Hein Plaque Index - PI, 1970. Previously, disclosing with erythrosine 3% solution,
plaque was scored on a six point scale from 0 (no plaque) to 5 (plaque covers two-thirds or
more of the tooth surface). Of the mesiobuccal, midbuccal, distobuccal, mesiolingual,
midlingual, and distolingual, of all scorable teeth was scored using the Turesky
modification of the Quigley-Hein Plaque Index - PI, 1970. There were also evaluated Severity
Plaque Index and Severity Gingival Index (Palomo et al., 1989; Volpe et al.,1993). These
index measured the rate of the surface that had high count of plaque (count similar to 3, 4,
5 of the modification Quigley-Hein Plaque Index, 1970) and high gingival index (count
similar to 2,3 modification Gingival Index of the Löe-Silness, 1977.
These examinations were all repeated after 45 and 90 days of use of mouthrinse. After
baseline examination, each subject received a complete oral prophylaxis, which included the
removal of all supragingival plaque and calculus deposits. Soon after, the subjects received
the 5% green propolis-containing mouthrinse alcohol-free (MGP 5%) and a toothbrush. They
were instructed to brush their teeth as usual and to rinse with the 10mL of MGP 5%, twice a
day, for one minute, right after their meals in the morning and at night. Participants were
required not to use another mouthrinse throughout the study. When new supplies were issued,
subjects returned their used materials, so that compliance to theproduct could be monitored.
Reproducibility of clinical examinations
All examinations were conducted by a single examiner trained to optimize the consistency of
the study. Prior to the study, the adviser trained the dental examiner, as a "gold
standard", directing him to introduce the periodontal probe, gently, into the gingival
sulcus,, keeping the instrument parallel to the long axis of the tooth, sliding it from the
distal to the mesial so delicately in the buccal and lingual surface of each evaluated
tooth. For calibration, there was examined nine subjects not included in the study.
For the plaque index it was performed a theoretical calibration. Soon after, photos were
used to obtain a standardization intra-examiner. The photos were exhibited by the adviser to
the examiner that noted the values of plaque index corresponding to each picture. After 15
days, the same pictures were exposed to the examiner that noted again the values of plaque
index. Next, the plaque index obtained in the first and second time was compared to verify
the level of intra-examiner. Then, we obtained a kappa value of 0.73, considered a
substantial estimate of reliability (Landis & Koch, 1977).
Statistical Analysis
The statistical package BioEstat version 4.0 was used for data analysis in this study. The
average adjusted in the baseline for both scores of the modified Plaque Index of
Quigley-Hein (1970) and modified Gingival Index of Löe-Silness (1977) as for the
corresponding severity scores, for being a non-parametric distribution, were compared
through covariance analysis, by Friedman test for data obtained at 45 and 90 days of the
study. All statistical tests of hypotheses had two strands and was considered a significance
level of p< 0.05 (Allen et al. 1998; Arweiler et al., 2001).
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05568290 -
Interleukin-38 Levels in Individuals With Periodontitis
|
||
Completed |
NCT04402996 -
Meteorin-like Levels in Individuals With Periodontitis
|
||
Not yet recruiting |
NCT06016023 -
Evaluation of Macrophage Inflammatory Protein-1α as a Periodontal Disease Biomarker
|
||
Not yet recruiting |
NCT05497895 -
The Assessment of Clinical Efficacy of Topical Application of 5% Thymoquinone Gel for Gingivitis Patients
|
Early Phase 1 | |
Completed |
NCT02633345 -
Effects on Tablets Containing Probiotic Candidate Strains
|
N/A | |
Completed |
NCT02552589 -
Effect of Toothpaste on the Reduction of Plaque and Inflammation
|
N/A | |
Completed |
NCT02884817 -
Essential Oil+ELA, Plaque and Gingivitis
|
Phase 4 | |
Completed |
NCT02980497 -
Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study
|
N/A | |
Unknown status |
NCT01956656 -
Efficacy Of Lotus Leaves In Management Of Plaque Induced Gingivitis
|
N/A | |
Completed |
NCT02515929 -
Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs
|
Phase 4 | |
Completed |
NCT02235532 -
Effects of Aloe Vera Toothpaste on Periodontal Parameters
|
N/A | |
Completed |
NCT02508987 -
Obesity and Oxidative Stress in Patients With Different Periodontal Status
|
N/A | |
Completed |
NCT01941797 -
Experimental Peri-implant Mucositis in Humans
|
N/A | |
Unknown status |
NCT01197105 -
Evaluation Study of a Mouthwash Based on Schinus Terebinthifolius to Treat Gingivitis in Children
|
Phase 1/Phase 2 | |
Completed |
NCT01593540 -
Clinical Examination of Metal Free Interdental Brushes
|
Phase 4 | |
Completed |
NCT01236963 -
Essential Oils Mouth Rinse and Dental Floss: Efficacy on Interproximal Gingivitis and Dental Plaque Accumulation
|
N/A | |
Completed |
NCT02102295 -
Effects of Antioxidant Dentifrice on Gingivitis
|
Phase 3 | |
Completed |
NCT06140784 -
A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices
|
N/A | |
Completed |
NCT02937636 -
To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population
|
N/A | |
Completed |
NCT06212908 -
Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer
|
N/A |